Publication | Closed Access

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

ThrombosisIschemic StrokeCardiovascular DiseaseMedicineNon-valvular Atrial FibrillationCardiovascular PharmacologyPharmacotherapyNeurologyStroke PreventionCoagulopathyCerebral Blood FlowStrokeAnticoagulantSportif Iii